All three groups displayed features of NAFLD, with increased lipogenesis mediated by sterol regulatory element binding protein 1c (SREBP-1c), peroxisome proliferator-activated receptor γ (PPARγ) and reduced peroxisome proliferator-activated receptor α (PPARα). This evidence concerns the gene SREBF1 and metabolic dysfunction-associated steatotic liver disease.